Dosing
Find the right dose of BELSOMRA for each patient.
For appropriate adult patients with insomnia who have trouble falling asleep and/or staying asleep.
BELSOMRA®
(suvorexant) 5, 10, 15, 20 mg tablets, for oral use, C-IV
Dosing
For appropriate adult patients with insomnia who have trouble falling asleep and/or staying asleep.
When used with moderate CYP3A inhibitors, the recommended dosage of BELSOMRA is 5 mg taken no more than once per night (the dose generally should not exceed 10 mg). BELSOMRA is not recommended for use with strong CYP3A inhibitors.
Inform your patients about the importance of reading the Medication Guide.
Urge patients to let you know promptly if they are still having trouble sleeping or experiencing other issues.
Be sure to discuss the importance of sleep hygiene and recommend an adequate trial period.
BELSOMRA® (suvorexant) is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.
Before prescribing BELSOMRA, please read the Prescribing Information. The Medication Guide also is available.